Ryan Douglas (executive)

Ryan Douglas is an American-Canadian CEO, inventor and roboticist specializing in medical device design and manufacturing. His work has led to the development of multiple commercial medical treatments for depression, traumatic brain injury, hypertension, Sleep disorder, and more. Additionally, Douglas has also developed and co-authored patents for numerous medical technologies, including robotically steerable cathetersand autonomous treatment systems.
Douglas most recently served as the CEO, President, and Co-Chairman for Nextern Innovation, where he oversaw the development and launch of more than 20 FDA-approved therapeutic and diagnostic medical devices.
== Career ==
Douglas is a former partner and board member of ReconRobotics, Inc., an advanced robotics company that has pioneered the use of tactical micro-robots for use by law enforcement and the United States Armed Forces|United States military, based on research initially funded by the DARPA|Defense Advanced Research Projects Agency (DARPA) and the National Science Foundation.
During Douglas’ tenure, ReconRobotics became the first micro-robotics manufacturer to be awarded a U.S. government contract. The United States military, including the United States Navy SEALs|Navy SEALs and dozens of international forces, have utilized the company's systems in high-risk urban warfare and surveillance operations to map and clear compounds, identify Improvised explosive device|improvised explosive devices (IEDs), enemy fighters, friendly forces, and local civilians. ReconRobotics models are also currently employed by more than 550 law enforcement agencies around the world, including the FBI, Bureau of Alcohol, Tobacco, Firearms and Explosives|ATF, United States Department of State|State Department, and United States Marshals Service|U.S. Marshals Service.
Douglas subsequently joined Verilux, a leading manufacturer of light therapy and Ultraviolet germicidal irradiation|ultraviolet sterilization devices, as CEO in 2009. Douglas invented multiple innovations in both fields for manufacture by Verilux, including the smallest, non-Light-emitting diode|LED device for the treatment of Seasonal affective disorder|Seasonal Affective Disorder (SAD) and other medical conditions, as well as handheld UV-C sanitizing devices and other cleaning technologies for the neutralization of Virus|viruses, bacteria, and Bed bug|bedbug larvae. Douglas' products have been regularly cited as among the best in the field by media outlets covering consumer goods, health, and technology, including The New York Times, The Chicago Tribune, Shape Magazine, Health.com, Mashable, Dwell, and have been consistently ranked among the top-selling light therapy products in North America.
During his time at Verilux, Douglas also served as the CEO and President of multinational medical device manufacturer Nextern Innovation (formerly MFG Solutions) before assuming the role of Co-Chairman in 2019. During that time, Douglas led research and co-authored multiple patents on behalf of Nextern for a variety of new medical technologies, including robotically augmented therapy delivery devices, modular Bioprocessor|bio-processors, Cell growth|cellular growth chambers, and novel systems for the collection and distribution of medical data, among many others.
Category:American business executives
Category:Inventors